Amit Kulkarni

3.6k total citations
35 papers, 706 citations indexed

About

Amit Kulkarni is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Amit Kulkarni has authored 35 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in Amit Kulkarni's work include Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (6 papers). Amit Kulkarni is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Lung Cancer Research Studies (6 papers). Amit Kulkarni collaborates with scholars based in United States, India and Austria. Amit Kulkarni's co-authors include Rahul Kanwar, Andreas S. Beutler, Michaela S. Banck, Matthew M. Ames, Julie M. Cunningham, Gary P. Schroth, Charles L. Loprinzi, Kay Minn, Franziska Metge and Lizhi Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Amit Kulkarni

32 papers receiving 698 citations

Peers

Amit Kulkarni
V. V. Moroz Russia
Stefan Koschnick Germany
Andrea Di Domenicantonio Italy
Zhaohui Wang China
R. A. Geerdink Netherlands
Jingwen Wang China
Ziad Salem Lebanon
N Matsumoto Japan
Yucheng Wang China
William Nassib William United States
V. V. Moroz Russia
Amit Kulkarni
Citations per year, relative to Amit Kulkarni Amit Kulkarni (= 1×) peers V. V. Moroz

Countries citing papers authored by Amit Kulkarni

Since Specialization
Citations

This map shows the geographic impact of Amit Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amit Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amit Kulkarni more than expected).

Fields of papers citing papers by Amit Kulkarni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amit Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amit Kulkarni. The network helps show where Amit Kulkarni may publish in the future.

Co-authorship network of co-authors of Amit Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Amit Kulkarni. A scholar is included among the top collaborators of Amit Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amit Kulkarni. Amit Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kulkarni, Amit, et al.. (2025). Is hydrogen preferentially picked- up in IPHWR's pressure tubes over deuterium?. Journal of Nuclear Materials. 616. 156032–156032.
2.
Ramakrishna, Karan, Manish R. Patel, Naomi Fujioka, Robert A. Kratzke, & Amit Kulkarni. (2024). Perioperative Strategies in Non-Small Cell Lung Cancer: Immunotherapy and Targeted Therapy. 4(1). 29–46. 1 indexed citations
3.
Kulkarni, Amit, Aditya Jain, Patricia Jewett, et al.. (2024). Association of antibiotic exposure with residual cancer burden in HER2-negative early stage breast cancer. npj Breast Cancer. 10(1). 24–24. 4 indexed citations
4.
Gupta, Arjun, Paul Nguyen, Andrew Robinson, et al.. (2024). Trajectories of Health Care Contact Days for Patients With Stage IV Non–Small Cell Lung Cancer. JAMA Network Open. 7(4). e244278–e244278. 18 indexed citations
5.
6.
Patel, Sandip Pravin, Nathaniel J. Myall, Amit Kulkarni, et al.. (2022). Resistance to EGFR Tyrosine Kinase Inhibitor Therapy in Non–Small-Cell Lung Cancer via Newly Acquired Targetable Oncogenic Driver Alterations With an Emphasis on BRAF: Case Series and Literature Review of Treatment. JCO Precision Oncology. 6(6). e2100551–e2100551. 4 indexed citations
7.
Kulkarni, Amit, et al.. (2021). Is It Time to Implement Adjuvant Targeted Therapy inEGFR-Mutant Non–Small-Cell Lung Cancer?. JCO Precision Oncology. 5(5). 408–414. 5 indexed citations
8.
Kulkarni, Amit, et al.. (2021). Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer. Clinical Medicine Insights Oncology. 15. 1353125449–1353125449. 16 indexed citations
9.
Kulkarni, Amit, Beibei Xu, Haitao Chu, et al.. (2020). Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis. Blood Cancer Journal. 10(3). 33–33. 26 indexed citations
10.
Kulkarni, Amit, Maryam Ebadi, Mohamad Aghaie Meybodi, et al.. (2020). Comparative analysis of antibiotic exposure association with clinical outcomes of chemotherapy versus immunotherapy across three tumour types. ESMO Open. 5(5). e000803–e000803. 26 indexed citations
11.
Kulkarni, Amit, et al.. (2019). MA07.09 Impact of Body Mass Index on Clinical Outcomes of Immune Checkpoint Blockers in Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 14(10). S275–S276. 2 indexed citations
12.
Nasa, Prashant, et al.. (2018). An observational epidemiological study of exercise-induced rhabdomyolysis causing acute kidney injury: A single-center experience. Indian Journal of Nephrology. 28(2). 105–105. 2 indexed citations
13.
Yeo, Leonard L.L., et al.. (2015). Reperfusion Therapies in Acute Ischemic Stroke. PubMed. 10(1). 45–54. 1 indexed citations
14.
Podratz, Jewel L., Amit Kulkarni, Rahul Kanwar, et al.. (2015). Neurotoxicity to DRG neurons varies between rodent strains treated with cisplatin and bortezomib. Journal of the Neurological Sciences. 362. 131–135. 21 indexed citations
15.
Kulkarni, Amit, Rahul Kanwar, Peter Beyerlein, et al.. (2015). Association of the Charcot–Marie–Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance). Journal of the Neurological Sciences. 357(1-2). 35–40. 39 indexed citations
16.
Kanwar, Rahul, Amit Kulkarni, Matthew M. Ames, et al.. (2015). Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines. Cancer Genetics. 208(7-8). 374–381. 67 indexed citations
17.
Banck, Michaela S., Rahul Kanwar, Amit Kulkarni, et al.. (2013). The genomic landscape of small intestine neuroendocrine tumors. Journal of Clinical Investigation. 123(6). 2502–2508. 208 indexed citations
18.
Sharma, Satyavan, et al.. (2010). Percutaneous transluminal renal stenting for transplant renal artery stenosis. Catheterization and Cardiovascular Interventions. 77(2). 287–293. 11 indexed citations
19.
Sharma, Satyavan, et al.. (2010). Severe pulmonary hypertension in a young patient with end-stage renal disease on chronic hemodialysis. Annals of Pediatric Cardiology. 3(2). 184–184. 6 indexed citations
20.
Bharucha, Adil E., Amit Kulkarni, Kyung Mook Choi, et al.. (2009). First-in-Human Study Demonstrating Pharmacological Activation of Heme Oxygenase-1 in Humans. Clinical Pharmacology & Therapeutics. 87(2). 187–190. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by V. V. Moroz Breakdown of academic impact, for papers by Stefan Koschnick Breakdown of academic impact, for papers by Andrea Di Domenicantonio Breakdown of academic impact, for papers by Zhaohui Wang Breakdown of academic impact, for papers by R. A. Geerdink Breakdown of academic impact, for papers by Jingwen Wang Breakdown of academic impact, for papers by Ziad Salem Breakdown of academic impact, for papers by N Matsumoto Breakdown of academic impact, for papers by Yucheng Wang Breakdown of academic impact, for papers by William Nassib William
Rankless by CCL
2026